ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Anika Therapeutics Inc

Anika Therapeutics Inc (ANIK)

14,59
0,39
(2,75%)
Beim Schlusskurs: 24 Juni 10:00PM
14,59
0,02
( 0,14% )
Nach Börsenschluss: 10:01PM

Anika Therapeutics Inc (ANIK) Insidergeschäfte

-
Filtern nach:
Datum Name des Inhabers Gehandelte Aktien Wertspanne ($) Transaktionstyp Preisspanne ($) Aktien am Meldungsende % Veränderung
2026-06-03Mr. Stephen D. GriffinPresident, Principal Financial Officer, CEO & Director-3,77k54,31kDerivative Exercise and Sale14,4145,97k-
2026-06-03Mr. Stephen D. GriffinPresident, Principal Financial Officer, CEO & Director9,07k0,00Derivative Exercise and Retained Stock-45,97k24,58%
2026-05-01Mr. John B. HennemanLead Independent Director5,00k73,32kKauf14,6654,87k10,03%
2026-04-30Mr. Stephen D. GriffinPresident, Principal Financial Officer, CEO & Director12,20k149,88kKauf12,2936,16k50,91%
2026-03-15Mr. David ColleranInsider-1,89k26,88kDerivative Exercise and Sale14,2067,57k-
2026-03-14Mr. David ColleranInsider13,94k0,00Derivative Exercise and Retained Stock-67,57k26,00%
2026-03-14Mr. David ColleranInsider-4,17k59,19kSale to Issuer14,2067,57k-5,81%
2026-03-14Mr. Stephen D. GriffinPresident, Principal Financial Officer, CEO & Director-5,94k84,40kSale to Issuer14,2023,96k-19,87%
2026-03-14Mr. Stephen D. GriffinPresident, Principal Financial Officer, CEO & Director12,82k0,00Derivative Exercise and Retained Stock-23,96k115,13%
2026-03-14Dr. Cheryl Renee BlanchardExecutive Chair37,55k0,00Derivative Exercise and Retained Stock-270,53k16,12%
2026-03-14Dr. Cheryl Renee BlanchardExecutive Chair-14,73k209,14kSale to Issuer14,20270,53k-5,16%
2026-03-15Dr. Cheryl Renee BlanchardExecutive Chair-12,10k171,88kDerivative Exercise and Sale14,20270,53k-
2026-03-15Mr. Ian W. McLeodSenior VP, CAO & Treasurer-781,0011,09kDerivative Exercise and Sale14,2024,11k-
2026-03-14Mr. Ian W. McLeodSenior VP, CAO & Treasurer5,65k0,00Derivative Exercise and Retained Stock-24,11k30,62%
2026-03-14Mr. Ian W. McLeodSenior VP, CAO & Treasurer-1,45k20,58kSale to Issuer14,2024,11k-5,67%
2026-03-09Dr. Cheryl Renee BlanchardExecutive Chair14,13k0,00Derivative Exercise and Retained Stock-223,19k6,76%
2026-03-09Dr. Cheryl Renee BlanchardExecutive Chair-5,87k87,83kDerivative Exercise and Sale14,96223,19k-
2026-03-09Mr. David ColleranInsider-1,92k28,71kDerivative Exercise and Sale14,9653,10k-
2026-03-09Mr. David ColleranInsider3,55k0,00Derivative Exercise and Retained Stock-53,10k7,16%
2026-03-09Mr. Ian W. McLeodSenior VP, CAO & Treasurer-639,009,56kDerivative Exercise and Sale14,9618,74k-
2026-03-09Mr. Ian W. McLeodSenior VP, CAO & Treasurer1,56k0,00Derivative Exercise and Retained Stock-18,74k9,07%

Kürzlich von Ihnen besucht

Delayed Upgrade Clock